Shaping Light at the Nanoscale for Precision Medicine

Nanophotonics—the manipulation of light at the nanometre scale—is reshaping modern biomedicine. By harnessing principles such as surface plasmon resonance and optical confinement, scientists are creating advanced tools for molecular imaging and photobiology. Biocompatible nanomaterials, including quantum dots, gold nanoparticles, and photonic metamaterials, now allow for highly sensitive biosensing, enabling doctors to detect diseases earlier and with greater precision.

Beyond diagnostics, this field is driving new image-guided interventions. Targeted photothermal and photodynamic therapies utilise near-infrared (NIR) and NIR-II light to penetrate deep into tissue, destroying specific targets with minimal collateral damage to healthy cells. Innovations are also shrinking these technologies into lab-on-a-chip platforms for rapid point-of-care testing.

Crucially, machine learning is being integrated to optimise these probes and interpret complex data in real time, building patient-specific predictive models. While advancements from 2021–2025 show immense promise, hurdles regarding biocompatibility, light penetration limits, and scalability remain before widespread clinical adoption can be realised.